Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
acimtamig (AFM13)
i
Other names:
AFM13, AFM 13, AFM13 TandAb
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(3)
News
Trials
Company:
Affimed, Xoma
Drug class:
CD16A agonist, CD30 inhibitor
Related drugs:
‹
AFM24 (3)
AFM13/AB-101 (1)
CTX-8573 (1)
AFM28 (0)
AFVT-2101 (0)
RO7297089 (0)
CD30 biAb-AATC (0)
GEN3017 (0)
AFM24 (3)
AFM13/AB-101 (1)
CTX-8573 (1)
AFM28 (0)
AFVT-2101 (0)
RO7297089 (0)
CD30 biAb-AATC (0)
GEN3017 (0)
›
Associations
(3)
News
Trials
VERI cancer hierarchy
Reset Filters
TNFRSF8 positive
Lymphoma
TNFRSF8 positive
Lymphoma
AFM13
Sensitive: C2 – Inclusion Criteria
AFM13
Sensitive
:
C2
AFM13
Sensitive: C2 – Inclusion Criteria
AFM13
Sensitive
:
C2
TNFRSF8 positive
Hodgkin Lymphoma
TNFRSF8 positive
Hodgkin Lymphoma
AFM13
Sensitive: C2 – Inclusion Criteria
AFM13
Sensitive
:
C2
AFM13
Sensitive: C2 – Inclusion Criteria
AFM13
Sensitive
:
C2
TNFRSF8 expression
Peripheral T-cell Lymphoma
TNFRSF8 expression
Peripheral T-cell Lymphoma
AFM13
Sensitive: C3 – Early Trials
AFM13
Sensitive
:
C3
AFM13
Sensitive: C3 – Early Trials
AFM13
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login